ACAD ACADIA PHARMACEUTICALS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 25 analyst firms say about ACADIA PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
22 rated views · 25 analyst/firm records · 25 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8046
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8046
Recent analyst activity · last 90 days
Our tracked history has 26 reports on ACAD from 16 analyst firms in the last 90 days (25 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 3 lowered it, 5 left it unchanged and 4 have their first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: RBC Capital raised its target from $36.00 (set 8 Oct 2026) to $38.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Jack K Allen | Buy | 26 Jun 2026 | 31.00 USD |
| Bank of America Securities | Tazeen Ahmad | Buy | 29 Jul 2026 | 14.50 USD |
| BMO Capital Markets | Evan David Seigerman | Buy | 24 Sep 2026 | 34.00 USD |
| Canaccord Genuity | Sumant Kulkarni | Buy | 29 Jun 2026 | 36.00 USD |
| Citigroup | Yigal Nochomovitz | Buy | 25 Sep 2026 | 33.00 USD |
| Citizens JMP | Jason N. Butler | Buy | 25 Sep 2026 | 33.00 USD |
| Deutsche Bank | David Hoang | Buy | 25 Sep 2026 | 31.00 USD |
| Goldman Sachs | Salveen Richter | Sell | 22 Oct 2026 | 16.00 USD |
| Guggenheim | Yatin Suneja | Hold | 18 Sep 2026 | — |
| H.C. Wainwright | Ananda Ghosh | Buy | 25 Sep 2026 | 33.00 USD |
| JPMorgan | Tessa Romero | Buy | 4 Mar 2026 | 34.00 USD |
| Leerink Partners | Marc Goodman | Buy | 25 Aug 2026 | 30.00 USD |
| Mizuho | Uy Ear | Buy | 23 Feb 2026 | 35.00 USD |
| Morgan Stanley | Jeffrey Hung | Hold | 25 Aug 2026 | 28.00 USD |
| Needham | Ami Fadia | Buy | 19 Oct 2026 | 35.00 USD |
| Oppenheimer | Matthew Hershenhorn | Hold | 23 Sep 2026 | — |
| Piper Sandler | Unnamed analyst | — | 16 Dec 2025 | 37.00 USD |
| RBC Capital Markets | Brian Abrahams | Buy | 8 Oct 2026 | 36.00 USD |
| Stifel | Paul Matteis | Hold | 21 Jul 2026 | 25.00 USD |
| TD Cowen | Ritu S Baral | Buy | 24 Sep 2026 | 37.00 USD |
| UBS | Ashwani Verma | Hold | 13 Oct 2026 | 23.00 USD |
| Weiss Ratings | Unnamed analyst | — | 12 Aug 2026 | — |
| William Blair | Unnamed analyst | — | 28 Sep 2026 | 33.00 USD |
| Wolfe Research | Rudy Li | Buy | 28 Jul 2026 | 34.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | 22.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:49 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.